Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis

Abstract Background Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiographic parameters of systolic and diastolic dysfunctio...

Full description

Bibliographic Details
Main Authors: Somayye Norouzi, Ali Javinani, Arya Aminorroaya, Maryam Masoumi
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cardiovascular Disorders
Subjects:
Autoantibodies
Anti-citrullinated protein antibodies
Anti-modified citrullinated vimentin
Anti-MCV
Arthritis, rheumatoid
Rheumatoid factor
Online Access:http://link.springer.com/article/10.1186/s12872-020-01676-x

Internet

http://link.springer.com/article/10.1186/s12872-020-01676-x

Similar Items